An official website of the United States government
News
PETAL-VIOLET Biospecimens Available
Posted on November 14, 2024
Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET) study are now available for request.
New Study: PETAL-ASTER (data and specimens)
Posted on November 14, 2024
A new study, Prevention and Early Treatment of Acute Lung Injury (PETAL) Acetaminophen in Sepsis: Targeted Therapy to Enhance Recovery (ASTER), has been posted to BioLINCC. Data and specimens from this study are available for requests.
New Study: BEST-CLI (data)
Posted on November 12, 2024
A new study, Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST-CLI), has been posted to BioLINCC. Data from this study are available for requests.
New Study: ICU-RESUS (data)
Posted on October 21, 2024
A new study, Improving Outcomes After Pediatric Cardiac Arrest (ICU-RESUS), has been posted to BioLINCC. Data from this study are available for requests.
New Study: BMT CTN-1401 (data)
Posted on October 18, 2024
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma With or Without Vaccination With Dendritic Cell/Myeloma Fusions (1401), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for CARDIA
Posted on October 11, 2024
Data have been updated for the CARDIA study (Coronary Artery Risk Development in Young Adults). Available data for request include exam data through Year 30 and outcomes and death data through 2022. Additionally, data from 28 ancillary studies are available for request including 10 new studies in this update.
Data Update for PETAL-CLOVERS
Posted on September 20, 2024
Data have been updated for the Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) study. This update includes Long Term Outcome data.
Data Update for ARIC Study
Posted on August 30, 2024
Data have been updated for the Atherosclerosis Risk in Communities Study (ARIC) study including exam cycle v8, annual follow-up communication data for year 32, and data from the Proteomics ancillary study. Now available are data from v1-v8 examination cycles, collated annual follow-up communication data for contact years 2-32, and follow-up for mortality, heart disease, and stroke events through 2019 in addition to 21 ancillary studies.
Note, ARIC data is no longer available for request by for-profit entities.
New Study: TOP (data)
Posted on August 9, 2024
A new study, Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?, has been posted to BioLINCC. Data from this study are available for requests.
Data Update for MESA
Posted on July 5, 2024
Data have been updated for the Multi-Ethnic Study of Atherosclerosis (MESA). This update includes the addition of the AS039 Air Pollution ancillary study.
New Study: BMT CTN-1703 (data)
Posted on July 3, 2024
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (1703), has been posted to BioLINCC. Data from this study are available for requests.
New Study: CTSN-AFB (data)
Posted on May 31, 2024
A new study, Cardiothoracic Surgical Trials Network (CTSN) Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery (AFB), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for ARIC Study
Posted on May 17, 2024
Data have been updated for the Atherosclerosis Risk in Communities Study (ARIC) study including cohort follow-up data through 2019, annual follow-up communication data for years 30 and 31, and data from the Brain MRI ancillary study, the ApoE ancillary study, the GDF-15 v6 ancillary study, and nine v7 ancillary studies. Now available are data from v1-v7 examination cycles, collated annual follow-up communication data for contact years 2-31, and follow-up for mortality, heart disease, and stroke events through 2019 in addition to 20 ancillary studies.
New Study: TRIM (data)
Posted on May 15, 2024
A new study, Trial of Roflumilast in Asthma Management (TRIM), has been posted to BioLINCC. Data from this study are available for requests.
New Study: SCDIC Registry (data)
Posted on April 25, 2024
A new study, Sickle Cell Disease Implementation Consortium (SCDIC) Sickle Cell Disease Patient Registry, has been posted to BioLINCC. Data from this study are available for requests.
New Study: CCTRN-CONCERT HF (data)
Posted on April 10, 2024
A new study, Cardiovascular Cell Therapy Research Network (CCTRN) A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF (CONCERT HF), has been posted to BioLINCC. Data from this study are available for requests.
New Study: CTSN-NP (data)
Posted on March 11, 2024
A new study, Cardiothoracic Surgical Trials Network (CTSN) Neuroprotection in Patients Undergoing Aortic Valve Replacement (NP), has been posted to BioLINCC. Data from this study are available for requests.
New Study: BMT CTN-1502 (data)
Posted on March 8, 2024
A new study, Blood and Marrow Clinical Trials Network (BMT CTN) Optimizing Haploidentical Aplastic Anemia Transplantation (CHAMP 1502), has been posted to BioLINCC. Data from this study are available for requests.
New Study: PETAL-FIRE CORAL (data and specimens)
Posted on March 1, 2024
A new study, Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Functional, imaging, and respiratory evaluation in CORAL (FIRE CORAL), has been posted to BioLINCC. Data and specimens from this study are available for requests.
Data Update for DISC
Posted on January 24, 2024
Data have been updated for the Dietary Intervention Study in Children (DISC). This update includes the addition of metabolomics and hormone data.
New Study: HFN-LIFE (data)
Posted on January 19, 2024
A new study, Heart Failure Network (HFN) - EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for FHS-Gen III
Posted on January 17, 2024
Data have been updated for the Framingham Heart Study (FHS) Third Generation (Gen III), OMNI 2, and New Offspring (NOS) Cohorts. This update includes the addition of Brain MRI data.
Data Update for FHS-Offspring
Posted on January 17, 2024
Data have been updated for the Framingham Heart Study-Offspring (FHS-OS). This update includes the addition of Brain MRI data.
New Study: CTSN-MMR (data)
Posted on December 15, 2023
A new study, Cardiothoracic Surgical Trials Network (CTSN) Surgical Interventions for Moderate Ischemic Mitral Regurgitation (MMR), has been posted to BioLINCC. Data from this study are available for requests.
PETAL-BLUE CORAL Biospecimens Available
Posted on December 5, 2023
Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Biology and Longitudinal Epidemiology of PETAL COVID-19 Observational Study (BLUE CORAL) study are now available for request.
Funding Opportunity: PAR-23-036 Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
Posted on December 9, 2022
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses using existing human datasets in areas relevant to the National Heart, Lung, Blood Diseases and Sleep Disorders Institute (NHLBI) scientific mission. The FOA aims to stimulate the use of existing human datasets to investigate novel scientific ideas, and/or generate new models, systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. Generation of new primary data is not allowed.
For more information on PAR-23-036 please visit:
https://grants.nih.gov/grants/guide/pa-files/PAR-23-036.html